Oec
Payments companies reported to CMS as associated with Oec. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Oec, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Oec
These are the largest totals companies reported as associated with Oec. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Jantz | Gainesville, FL | Pulmonary Disease | $60,929.34 |
| Gustavo Cumbo Nacheli | Grand Rapids, MI | Pulmonary Disease | $55,515.55 |
| Bradley Pua | New York, NY | Vascular & Interventional Radiology | $36,662.08 |
| Benjamin Seides | Winfield, IL | Pulmonary Disease | $26,707.68 |
| Henry Dalsania | Memphis, TN | Vascular & Interventional Radiology | $25,072.30 |
| Kentaro Yamada | San Diego, CA | Ophthalmology | $20,672.10 |
| Lorenzo Azzalini | Seattle, WA | Interventional Cardiology | $20,370.06 |
| Ernest Braxton | Edwards, CO | Neurological Surgery | $20,073.01 |
| Shailendra Singh | Allentown, PA | Interventional Cardiology | $17,426.70 |
| Dominique Pepper | Olympia, WA | Pulmonary Disease | $16,774.56 |
Prescribed Oec?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.